Identification of HDAC6-Selective Inhibitors of Low Cancer Cell Cytotoxicity-Reference-Cited by-同舟云学术

Identification of HDAC6-Selective Inhibitors of Low Cancer Cell Cytotoxicity

Published:2015-11-23 Issue:1 Volume:11 Page:81-92
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Gaisina Irina N.¹²,Tueckmantel Werner²,Ugolkov Andrey³,Shen Sida¹,Hoffen Jessica³,Dubrovskyi Oleksii³⁴,Mazar Andrew³⁴,Schoon Renee A.⁵,Billadeau Daniel⁵,Kozikowski Alan P.¹

Affiliation:

1. Drug Discovery Program, Department of Medicinal Chemistry and Pharmacognosy; College of Pharmacy; University of Illinois at Chicago; Chicago IL 60612 USA

2. Psychogenics Inc.; Tarrytown NY 10591 USA

3. Center for Developmental Therapeutics; Feinberg School of Medicine; Northwestern University; Evanston IL 60208 USA

4. Department of Pharmacology; Feinberg School of Medicine; Northwestern University; Evanston IL 60208 USA

5. Department of Immunology and Division of Oncology Research; College of Medicine; Mayo Clinic; 13-42 Guggenheim Rochester MN 55905 USA

Funder

National Institutes of Health

Cancer Center Support Grant 2 P30

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Reference26 articles.

1. Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

2. Histone Acetyltransferases

3. Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code

4. Anticancer activities of histone deacetylase inhibitors

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterocycles–Containing HDAC Inhibitors Active in Cancer: An Overview of the Last Fifteen Years;ChemMedChem;2024-08-29

2. Development of First-in-Class Dual Sirt2/HDAC6 Inhibitors as Molecular Tools for Dual Inhibition of Tubulin Deacetylation;Journal of Medicinal Chemistry;2023-10-30

3. Difluoromethyl-1,3,4-oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase 6;Journal of Medicinal Chemistry;2023-10-02

4. Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-04-25

5. Design, Synthesis, Cytotoxic Effect Evaluation and Molecular Docking of (R)‐Camphor‐Based Thiazolidinone‐Isoxazole and Thiazolidinone‐1,2,3‐triazole Hybrids“;ChemistrySelect;2023-01-02